Pharmaceutical manufacturers face many unique challenges in this remarkable era. While technological advancements have multiplied opportunities for process improvements, regulatory oversight has allowed adoption compared to other industries. There are stringent requirements for documentation, process validation, and data integrity to create an environment where compliance outweighs continuous improvement.
Pharma 4.0 intends to bring a cultural shift by driving processes towards more human centric workflows. Connecting workers using digital technologies, the futuristic concept puts humans at the core of pharma manufacturing.
What are the Benefits of Pharma 4.0?
The concept of Pharma 4.0 is still relatively new, but there are already several benefits that pharmaceutical and life sciences companies are seeing. Some of the potential benefits that have been identified include the following:
Increased Quality through a End-to-end production overview
- Pharma 4.0 offers many digital capabilities, such as remote manufacturing equipment monitoring and predictive maintenance. Manufacturing inefficiencies can be identified to avoid batch failures.
- It follows a holistic approach – from facilitating raw material selection to reducing process variations.
Pharma 4.0 can help companies reduce costs by automating manual tasks, minimizing downtime, and reducing waste. At the same time, the increased quality that comes with Pharma 4.0 can help companies avoid the costs associated with recalls and other quality issues.
- Because Pharma 4.0 provides increased visibility into pharma manufacturing processes, it can help companies ensure compliance with regulations.
- Automated data collection and analysis can also help companies identify and correct deviations from standard operating procedures more quickly.
- Pharma 4.0 can help companies increase flexibility by enabling them to reconfigure their manufacturing processes.
- This could accommodate changes in product demand or quickly introduce new products to the market.
Improved Safety & Better patient outcomes
- The ability to track products throughout the supply chain can help companies improve product quality and safety.
- In addition, the automation of pharma manufacturing processes can help reduce workers’ exposure to hazardous materials.
- Delivering high product quality will also lead to better patient outcomes.
Real time monitoring
- Real time monitoring eliminates paper-based processes offering greater connectivity across departments and improving productivity.
Connected people, processes, and technology
- Industrial Internet of Things (IIoT) and Cyber Physical Systems (CPS) are helping enhance connectivity and improve productivity by bringing together humans and pharma technology.
Resource Person: BARBARA PIROLA